317 related articles for article (PubMed ID: 31838497)
1. The Effect of Perimenopausal Transdermal Estradiol and Micronized Progesterone on Markers of Risk for Arterial Disease.
Gordon JL; Rubinow DR; Watkins L; Hinderliter AL; Caughey MC; Girdler SS
J Clin Endocrinol Metab; 2020 May; 105(5):e2050-60. PubMed ID: 31838497
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of Transdermal Estradiol and Micronized Progesterone in the Prevention of Depressive Symptoms in the Menopause Transition: A Randomized Clinical Trial.
Gordon JL; Rubinow DR; Eisenlohr-Moul TA; Xia K; Schmidt PJ; Girdler SS
JAMA Psychiatry; 2018 Feb; 75(2):149-157. PubMed ID: 29322164
[TBL] [Abstract][Full Text] [Related]
3. Effects of micronized progesterone added to non-oral estradiol on lipids and cardiovascular risk factors in early postmenopause: a clinical trial.
Casanova G; Spritzer PM
Lipids Health Dis; 2012 Oct; 11():133. PubMed ID: 23046709
[TBL] [Abstract][Full Text] [Related]
4. The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.
Stephenson K; Neuenschwander PF; Kurdowska AK
Int J Pharm Compd; 2013; 17(1):74-85. PubMed ID: 23627249
[TBL] [Abstract][Full Text] [Related]
5. Postmenopausal hormone replacement therapy and cardiovascular disease: the value of transdermal estradiol and micronized progesterone.
Mueck AO
Climacteric; 2012 Apr; 15 Suppl 1():11-7. PubMed ID: 22432811
[TBL] [Abstract][Full Text] [Related]
6. Effects of Oral vs Transdermal Estrogen Therapy on Sexual Function in Early Postmenopause: Ancillary Study of the Kronos Early Estrogen Prevention Study (KEEPS).
Taylor HS; Tal A; Pal L; Li F; Black DM; Brinton EA; Budoff MJ; Cedars MI; Du W; Hodis HN; Lobo RA; Manson JE; Merriam GR; Miller VM; Naftolin F; Neal-Perry G; Santoro NF; Harman SM
JAMA Intern Med; 2017 Oct; 177(10):1471-1479. PubMed ID: 28846767
[TBL] [Abstract][Full Text] [Related]
7. Effects of perimenopausal transdermal estradiol on self-reported sleep, independent of its effect on vasomotor symptom bother and depressive symptoms.
Geiger PJ; Eisenlohr-Moul T; Gordon JL; Rubinow DR; Girdler SS
Menopause; 2019 Nov; 26(11):1318-1323. PubMed ID: 31688579
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal changes in menopausal symptoms comparing women randomized to low-dose oral conjugated estrogens or transdermal estradiol plus micronized progesterone versus placebo: the Kronos Early Estrogen Prevention Study.
Santoro N; Allshouse A; Neal-Perry G; Pal L; Lobo RA; Naftolin F; Black DM; Brinton EA; Budoff MJ; Cedars MI; Dowling NM; Dunn M; Gleason CE; Hodis HN; Isaac B; Magnani M; Manson JE; Miller VM; Taylor HS; Wharton W; Wolff E; Zepeda V; Harman SM
Menopause; 2017 Mar; 24(3):238-246. PubMed ID: 27779568
[TBL] [Abstract][Full Text] [Related]
9. What's new in hormone replacement therapy: focus on transdermal estradiol and micronized progesterone.
Simon JA
Climacteric; 2012 Apr; 15 Suppl 1():3-10. PubMed ID: 22432810
[TBL] [Abstract][Full Text] [Related]
10. Estradiol therapy combined with progesterone and endothelium-dependent vasodilation in postmenopausal women.
Gerhard M; Walsh BW; Tawakol A; Haley EA; Creager SJ; Seely EW; Ganz P; Creager MA
Circulation; 1998 Sep; 98(12):1158-63. PubMed ID: 9743505
[TBL] [Abstract][Full Text] [Related]
11. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
[TBL] [Abstract][Full Text] [Related]
12. Aortic hemodynamics in postmenopausal women following cessation of hormone therapy.
Harvey RE; Johnson MC; Ranadive SM; Joyner MJ; Lahr BD; Miller VM; Barnes JN
Physiol Rep; 2017 Dec; 5(23):. PubMed ID: 29208690
[TBL] [Abstract][Full Text] [Related]
13. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
Davis SR; Goldstat R; Newman A; Berry K; Burger HG; Meredith I; Koch K
Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213
[TBL] [Abstract][Full Text] [Related]
14. Long-term hormone therapy for perimenopausal and postmenopausal women.
Marjoribanks J; Farquhar C; Roberts H; Lethaby A; Lee J
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD004143. PubMed ID: 28093732
[TBL] [Abstract][Full Text] [Related]
15. Long term hormone therapy for perimenopausal and postmenopausal women.
Marjoribanks J; Farquhar C; Roberts H; Lethaby A
Cochrane Database Syst Rev; 2012 Jul; (7):CD004143. PubMed ID: 22786488
[TBL] [Abstract][Full Text] [Related]
16. Hemodynamic and metabolic effects of estrogen plus progestin therapy in hypertensive postmenopausal women treated with an ACE-inhibitor or a diuretic.
Posadzy-Malaczynska A; Rajpold K; Woznicka-Leskiewicz L; Marcinkowska J
Clin Res Cardiol; 2015 Jan; 104(1):38-50. PubMed ID: 25216597
[TBL] [Abstract][Full Text] [Related]
17. The route of administration, timing, duration and dose of postmenopausal hormone therapy and cardiovascular outcomes in women: a systematic review.
Oliver-Williams C; Glisic M; Shahzad S; Brown E; Pellegrino Baena C; Chadni M; Chowdhury R; Franco OH; Muka T
Hum Reprod Update; 2019 Mar; 25(2):257-271. PubMed ID: 30508190
[TBL] [Abstract][Full Text] [Related]
18. [The effect of transdermal hormone replacement therapy on vasomotor symptoms in perimenopausal women].
Rozmus-Warcholińska W; Skrzypulec V; Drosdzol A; Kowalczyk R; Nowosielski K; Piela B; Walaszek A
Wiad Lek; 2004; 57 Suppl 1():254-8. PubMed ID: 15884251
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular risk assessment with oxidised LDL measurement in postmenopausal women receiving intranasal estrogen replacement therapy.
Kurdoglu M; Yildirim M; Kurdoglu Z; Erdem A; Erdem M; Bilgihan A; Goktas B
Gynecol Endocrinol; 2011 Aug; 27(8):551-7. PubMed ID: 20670096
[TBL] [Abstract][Full Text] [Related]
20. Effects of transdermal and oral estrogen replacement on lipids and glucose metabolism in postmenopausal women with type 2 diabetes mellitus.
Araújo DA; Farias ML; Andrade AT
Climacteric; 2002 Sep; 5(3):286-92. PubMed ID: 12419087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
